Motion Filed to Consolidate Yasmin/YAZ Litigation in Toledo, Ohio
LANCASTER, Pa., July 24 /PRNewswire-USNewswire/ -- Three leading law firms representing 23 of the 32 filed cases around the country have filed a joint motion asking that the Yasmin/YAZ product liability litigation be consolidated and transferred to Chief Judge James G. Carr of the U...U.S. Patent Infringement Lawsuit Filed by Aperio Technologies, Inc.
HAMAMATSU, Japan, June 23 /PRNewswire/ -- A U.S. patent infringement lawsuit was filed on June 10, 2009, against Hamamatsu Photonics K.K., Hamamatsu Corporation, and Olympus America, Inc. The lawsuit, brought by Aperio Technologies, Inc. in the U.S. District Court for the District of Delaware, ac...Bionovo Announces Arbitration Decision in Lawsuit Filed by Former Officer - All Claims Denied
EMERYVILLE, Calif., June 11 /PRNewswire-FirstCall/ -- Bionovo, Inc. (Nasdaq: BNVI ) announced today that an arbitration decision issued on June 10, 2009 has denied all claims against the company and its founders, Drs. Isaac Cohen and Mary Tagliaferri. The decision was in reference to a sui...China Nepstar Chain Drugstore Filed 2008 Annual Report on Form 20-F
SHENZHEN, China, May 26 /PRNewswire-Asia-FirstCall/ -- China Nepstar Chain Drugstore Ltd. (NYSE: NPD ) ("China Nepstar" or the "Company"), the largest drugstore chain in China based on the number of directly operated stores, today announced that the Company filed its annual report on Form 20...Shire has Filed a Treatment Protocol for Velaglucerase Alfa for Gaucher Disease
LEXINGTON, Massachusetts, July 6 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY ), the global specialty biopharmaceutical company, announces that, at the request of the FDA, in view of a potential restriction on the availability of the current approved and marketed treatment fo...Keppra XR(TM) Extended-Release Tablets Filed with the FDA
U.S. Food and Drug Administration (FDA) has accepted for filing the New Drug Application (NDA) for the use of Keppra XR(TM) (levetiracetam) in the adjunctive treatment of partial onset seizures in adults with epilepsy ATLANTA, Jan. 16 /PRNewswire/ -- UCB announced today that the New Drug A...NewCardio Announces Master Services Agreement With Dedicated Phase I
...concerning factors that could cause our actual results to differ materially from these forward-looking statements can be found in our periodic reports filed with the Securities and Exchange Commission. We assume no obligation to, and do not currently intend to, update these forward-looking statements. ...Labopharm files New Drug Submission with Health Canada for novel antidepressant
... LAVAL, QC, Aug. 5 /PRNewswire-FirstCall/ - Labopharm Inc. (TSX: DDS; NASDAQ: DDSS ) today announced it has filed a New Drug Submission (NDS) with the Therapeutic Products Directorate of Health Canada for its novel formulation of the antidepressant trazodone. "W...Nektar Therapeutics Reports Second Quarter 2009 Financial Results
... forth in the company's Annual Report on Form 10-K filed with the Securities and Exchange Commission on Mar... on Form 10-Q for the quarter ended March 31, 2009 filed with the Securities and Exchange Commission on May...'s most recent Quarterly Report on Form 10-Q to be filed on or about August 5, 2009. Actual results could ...Pipet Verification Service - PVS
Description:...ed, standard deviation (SD), coefficient of variation (CV) and percent recovery. This data can be used to determine the performance of your pipets and filed for inspection purposes....Anthrax Vaccine Immunization Program
...re resumed [4] , but then an injunction against mandatory vaccination was filed on the basis that the BioPort Anthrax Vaccive Absorbed (AVA) was not prov...ages. [10] On December 13, 2006 , a new class-action lawsuit [11] , filed on behalf of six unnamed plaintiffs, revived the legal battle over the mili...BIO-key to Respond in Court to a Lawsuit Filed by Two Investors
WALL, N.J., March 4 /PRNewswire-FirstCall/ -- BIO-key International, Inc. (OTC Bulletin Board: BKYI), a leader in wireless public safety and finger-based biometric identification solutions, today announced that on or before March 16, 2009 it will file, in the United States District Court for the S...Identification of a key molecular pathway required for brain neural circuit formation
... of a novel technique to control and observe the behavior of axons in response to guidance molecules. A patent application for this technique has been filed recently. This invention is expected to speed up the discovery of drugs that control axon pathfinding. "Dr. Charron is one of the country's leading...Association for Molecular Pathology joins ACLU to challenge gene patents
...g hereditary breast and ovarian cancers. The lawsuit, Association for Molecular Pathology, et al. v. U.S. Patent and Trademark Office, et al., was filed May 12 in U.S. District Court for the Southern District of New York against the U.S. Patent and Trademark Office (PTO) and Myriad Genetics and the Uni...Aware, Inc. Amends and Extends Dutch Auction Tender Offer
...ent No. 1 and Amendment No. 2 (the "Schedule TO"), filed with the SEC in connection with the tender offer. ...se materials (and all other tender offer documents filed with the SEC) have been or will be filed with the SEC and will be available at no charge on...Allscripts Integrates Electronic Health Records with Innovative Patient Kiosk
...lly integrate third-party licensed technology; breach of our security by third parties; and the risk factors detailed from time to time in our reports filed with the Securities and Exchange Commission, including our 2007 Annual Report on Form 10-K available through the Web site maintained by the Securities...NIH funds development of resistance-breaking insecticides to reduce malaria transmission
...etain significant insecticidal activity against the malaria mosquito, they could prove ideal for deployment on ITNs. Two patent applications have been filed and commercial interest has been expressed in the potentially safer compounds, he said. "Second, we figured out how to inhibit target site-resistan...Einstein researchers devise a fast and sensitive way to detect ricin
...r changes will be needed to make detection of ricin by light practical for field and clinical applications. Albert Einstein College of Medicine has filed a patent application on the ricin detection method and is interested in licensing the technology to a company or organization that would develop it fu...Aware, Inc. Amends and Extends Dutch Auction Tender Offer
...ent No. 1 and Amendment No. 2 (the "Schedule TO"), filed with the SEC in connection with the tender offer. ...se materials (and all other tender offer documents filed with the SEC) have been or will be filed with the SEC and will be available at no charge on...Iowa State chemist synthesizes carbohydrates, launches startup company
...duction of complex carbohydrate molecules with multiple branches and long chains of sugars. The Iowa State University Research Foundation Inc. has filed for a patent of Pohl's technology. She says her process can fabricate a custom-order, complex carbohydrate molecule in 24 hours. Current commercial...Aware, Inc. Commences Dutch Auction Tender Offer
... Tender offer materials are being distributed to stockholders and are being filed with the Securities and Exchange Commission today. None of the Company...o them. In addition, all of those materials (and all other offer documents filed with the SEC) will be available at no charge on the SEC's web site, www.se...Alseres Pharmaceuticals, Inc. Complies with NASDAQ Rule Regarding Recently Filed 10-K
HOPKINTON, Mass., March 31 /PRNewswire-FirstCall/ -- Alseres Pharmaceuticals, Inc. (Nasdaq: ALSE ) today announced that the report of the Company's independent registered public accounting firm regarding the Company's 2008 financial statements contained an explanatory paragraph regarding the Com...Sigma-Aldrich (NASDAQ:SIAL) Announces it Has Filed Its December 31, 2008 Form 10-K
ST. LOUIS, Feb. 27 /PRNewswire-FirstCall/ -- A copy of the Company's December 31, 2008 Form 10-K, as filed with the Securities & Exchange Commission, may be obtained without charge at our website address, www.sigma-aldrich.com , or upon writing to the Secretary, Sigma-Aldrich Corporation, P. ...Inhaled Treprostinil New Drug Application Filed by FDA
SILVER SPRING, Md., Sept. 3 /PRNewswire-FirstCall/ -- United Therapeutics Corporation (Nasdaq: UTHR ) and its wholly-owned subsidiary Lung Rx, Inc. announced today that the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for inhaled treprostinil ...Hagens Berman Sobol Shapiro: Lawsuit Filed Against CellCyte Genetics Corporation
Hagens Berman suit claims company insiders knowingly misrepresented the company to investors SEATTLE, Jan. 18 /PRNewswire/ -- Hagens Berman Sobol Shapiro filed a proposed class-action lawsuit on behalf of CellCyte Genetics Corporation (OTC Bulletin Board: CCYG) shareho...Schering-Plough Announces Sugammadex New Drug Application Filed in Japan
KENILWORTH, N.J., Jan. 17 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: SGP ) announced that Nippon Organon K.K., now part of Schering-Plough, has filed a New Drug Application with the Japanese Ministry of Health, Labour and Welfare (MHLW) seeking marketing approval for its nov...Resverlogix's Success in Inflammation Program Results in 2 Patents Filed
Novel small molecules illustrate potential cost effective approach for rheumatoid arthritis TSX Exchange Symbol: RVX CALGARY and ATLANTA, May 19 /PRNewswire-FirstCall/ - Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) is pleased to announce today that it has made s...